Operating income Biotec Pharmacon ASA is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Biotec Pharmacon ASA is 1 522 000 kr Net income Biotec Pharmacon ASA is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Biotec Pharmacon ASA is 1 401 000 kr Current assets Biotec Pharmacon ASA is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Biotec Pharmacon ASA is 52 457 000 kr
|
|
31/12/2019
|
30/09/2019
|
30/06/2019
|
31/03/2019
|
|
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
|
21 472 000 kr |
17 207 000 kr |
13 762 000 kr |
13 054 000 kr |
|
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
|
4 106 000 kr |
6 749 000 kr |
5 217 000 kr |
2 829 000 kr |
|
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
|
25 578 000 kr |
23 956 000 kr |
18 979 000 kr |
15 883 000 kr |
|
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
|
25 578 000 kr |
23 956 000 kr |
18 979 000 kr |
15 883 000 kr |
|
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
|
1 522 000 kr |
-520 000 kr |
-1 896 000 kr |
-5 272 000 kr |
|
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
|
1 401 000 kr |
-281 000 kr |
-1 921 000 kr |
-5 291 000 kr |
|
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
|
- |
- |
- |
- |
|
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
|
24 056 000 kr |
24 476 000 kr |
20 875 000 kr |
21 155 000 kr |
|
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
|
52 457 000 kr |
50 352 000 kr |
45 204 000 kr |
47 874 000 kr |
|
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
|
78 270 000 kr |
77 477 000 kr |
73 212 000 kr |
76 859 000 kr |
|
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
|
31 289 000 kr |
22 055 000 kr |
21 369 000 kr |
28 190 000 kr |
|
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
|
18 327 000 kr |
13 910 000 kr |
9 031 000 kr |
10 424 000 kr |
|
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
|
- |
- |
- |
- |
|
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
|
30 979 000 kr |
30 581 000 kr |
26 342 000 kr |
28 377 000 kr |
|
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
|
39.58 % |
39.47 % |
35.98 % |
36.92 % |
|
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
|
45 960 000 kr |
45 888 000 kr |
46 001 000 kr |
47 652 000 kr |
|
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
|
13 471 000 kr |
1 966 000 kr |
-5 683 000 kr |
-3 305 000 kr |
